Benefit Of Continuing Therapy With Luspatercept In Patients With Beta-Thalassemia Who Do Not Achieve >=33% Reduction In Red Blood Cell (Rbc) Transfusion Burden (Tb) In Weeks 13-24 In The Believe Trial
Luspatercept
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Benefit Of Continuing Therapy With Luspatercept In Patients With Beta-Thalassemia Who Do Not Achieve >=33% Reduction In Red Blood Cell (Rbc) Transfusion Burden (Tb) In Weeks 13-24 In The Believe Trial ### Output: Luspatercept